23/02/15
‘DNA spellchecker’ means that our genes aren’t all equally likely to mutate and cause disease
A study that examined 17 million mutations in the genomes of 650 cancer patients concludes that large differences in mutation rates across the human genome are caused by the DNA repair machinery.
‘DNA spellchecker’ is preferentially...18/02/15
European Research Council grants: Good news for EU-LIFE centres, but with a bitter aftertaste
EU-LIFE European research centres obtained 14 new ERC Starting and Consolidator grants in the latest competitions, which takes the total of ERC-funded grants currently running in centres belonging to the alliance to over 100. As a whole, EU-LIFE...
16/02/15
Xavier Estivill, new member of the scientific and editorial board of 'Genética Médica News'
Xavier Estivill, head of the Genomics and Disease group at the CRG, has just been appointed to the scientific and editorial board of the Spanish journal “Genética Médica News”.
Genética Médica News is a journal that...
06/02/15
Evolution is shaped by the underlying dynamical mechanisms in our genome
To what extent does the dynamical mechanism responsible for a specific phenotype bias the ability to evolve into novel phenotypes?
Evolution is driven by mutations which can transform the...
30/01/15
OUR ALUMNI: Julia von Blume, group leader at the Max Planck Institute of Biochemistry, Germany
I did my PhD in the Thomas Seufferelin’s lab at the University of Ulm, Germany, where I investigated the compartment-specific function of a protein kinase that is overexpressed in pancreatic cancer, known as Protein Kinase D. During my PhD I met...
27/01/15
"Spark", a new public-private project created to develop a drug to fight the cognitive impairment associated with schizophrenia
The goal of «Spark» is to carry out the first preclinical stage of the development of a first-in-class drug that will prevent, stop and reverse the progression of cognitive impairment associated with schizophrenia and other mental disorders, and...